Title: Distinguishing the Therapeutic and Adverse Mechanisms of NMDAR Blockers

Kevin S. Jones is an assistant professor in the Department of Pharmacology at the University of Michigan Medical School. His research interests include the neurophysiology and neuropharmacology of mental health disorders. He holds a PhD in neuropharmacology from Duke University and has more than 20 years of experience in neurobiological research. His current work focuses on discovering new medicines for the treating of post-traumatic stress disorder, major depression, and schizophrenia. His work has appeared in many journals including Neuron, The Journal of Neuroscience, and the International Journal of Comparative Psychology. His past and current affiliations include the Instituto Ramón y Cajal in Madrid, Spain; Johns Hopkins University Medical School; College of Osteopathic Medicine of the Pacific; University of Cincinnati; Pomona College; and Charles Drew University Medical School. He is a member of the Society for Neuroscience, a past president of the DC metro chapter of SfN and currently serves as the chair of the NSP Subcommittee of the SfN Professional Development Committee. He is a member of the Executive Committee of Neuropharmacology Division of the American Society for Pharmacology and Experimental Therapeutics. In addition to managing his research team. He is a long-standing advocate for increasing the participation from underrepresented populations in neuroscience. Dr. Jones is also an award-winning instructor who enjoys teaching undergraduate and graduate students. In his spare time, he enjoys spending time with his family and coaching his sons football teams.